Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.54 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.54 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.54 |
| ▸ | APLNR | P35414 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 4/20 | 0.51 |
| ▸ | EP300 | Q09472 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | CALCR | P30988 | 6/20 | 0.50 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 3/20 | 0.48 |
| ▸ | NPY4R | P50391 | 3/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.48 |
| ▸ | NPY1R | P25929 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416004 | 0.90 | NPY2R (0.59) | MAPK8MAPK9MAPK10F2EP300 | |
| SCHEMBL30432802 | 0.89 | CALCR (0.56) | MAPK8MAPK9MAPK10CALCRNPY2R | |
| SCHEMBL29943968 | 0.89 | CALCR (0.60) | CALCRRAMP3KEAP1 | |
| SCHEMBL29608399 | 0.88 | NTSR2 (0.55) | APLNRF2 | |
| SCHEMBL29608877 | 0.87 | APLNR (0.50) | APLNRF2CALCRPLK1RAMP3 | |
| SCHEMBL29607122 | 0.87 | C5AR1 (0.56) | APLNRF2PLK1NPY2RNPY4R | |
| SCHEMBL29607016 | 0.87 | C5AR1 (0.56) | APLNRF2PLK1NPY2RNPY4R | |
| SCHEMBL30325295 | 0.87 | F2 (0.56) | APLNRF2CALCRNPY2RNPY4R | |
| SCHEMBL29416132 | 0.87 | APLNR (0.56) | APLNRF2 | |
| SCHEMBL30646310 | 0.87 | APLNR (0.56) | APLNRF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116490215-A | Targeted mediated endocytic drug delivery | CRM医疗有限公司 | 2023-07-25 | — | — | CN | disclosed |